Time Pharmaceuticals Signs NEPSE Agreement for Institutional Share Sale
Summary
Time Pharmaceuticals has signed an agreement with NEPSE to issue 4,34,600 shares to institutional investors via book-building, aiming to raise Rs. 10.86 crore with a total paid-up capital reaching Rs. 53 crore after the issuance.
Key Points
- Time Pharmaceuticals Limited has signed an agreement with the Nepal Stock Exchange to conduct a book-building process for share issuance.
- The company plans to issue 10,86,500 shares to raise Rs. 10.86 crore, with 40% allocated to institutional investors and 60% offered to the public.
- Time Pharmaceuticals has been operating for over 30 years, producing over 200 medicines with GMP certification.
- Post-issuance, the company’s total paid-up capital will be Rs. 53 crore.